Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Omotayo Okusanya Reiterated (DOC) at Hold and Held Target at $15 on, Mar 29th, 2023
Omotayo Okusanya of Credit Suisse, Reiterated "Healthpeak Properties, Inc." (DOC) at Hold and Held Target at $15 on, Mar 29th, 2023.
Omotayo has made no other calls on DOC in the last 4 months.
There are 4 other peers that have a rating on DOC. Out of the 4 peers that are also analyzing DOC, 1 agrees with Omotayo's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Carroll of "RBC Capital" Maintained at Hold with Decreased Target to $15 on, Tuesday, February 28th, 2023
These are the ratings of the 3 analyists that currently disagree with Omotayo
- Floris Van Dijkum of "Compass Point" Maintained at Strong Buy with Decreased Target to $19 on, Monday, March 27th, 2023
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $18 on, Tuesday, January 17th, 2023
- Todd Thomas of "Keybanc" Upgraded from Hold to Buy and Held Target at $17 on, Wednesday, December 14th, 2022
